Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

Phase 4

Completed

• Conditions: Macula Thickening

• Registration Number: NCT00433225
• Lead Sponsor: Innovative Medical

Brief Summary

The purpose of this study was to evaluate the efficacy of ketorolac 0.4% on quality of vision and macula thickening in patients undergoing cataract surgery using the ReStor® multifocal IOL.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-02-07
• Study First Submitted QC: 2007-02-08
• Study First Posted: 2007-02-09
• Status Verified: 2007-09
• Last Update Submitted: 2007-09-05
• Last Update Posted: 2007-09-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Males or females > 50 years old
• Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
• Likely to complete all study visits and able to provide informed consent
• Visual potential of 20/25 or better

Exclusion Criteria

• · Prior use of topical ketorolac

  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease
  • Active ocular allergies

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Ophthalmic Consultants of Long Island; 🇺🇸 Rockville Centre, New York, United States